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COVID-19 and Other Prevalent 
Diseases in Africa: A
Pragmatic Approach
Abstract
The aim of this paper is to propose that the development and legitimization of African 
knowledge and validation systems on a pragmatic basis is an efficient and effective 
means of responding to a myriad of health problems plaguing Africans, particularly the 
COVID-19 pandemic. Whenever there is a novel disease outbreak, the norm is to wait 
for the development of scientifically proven vaccines for its treatment. However, the 
scientific validation of drugs is a rigorous and lengthy process, thereby inappropriate for 
dealing with health emergencies like the COVID-19 outbreak. The alarming rapidity with 
which the novel COVID-19 pandemic rages globally and decimates humanity has brought 
to the fore the need for Africa to look inwards in search of viable and efficient alternative 
approaches to the pandemic. In this paper, I examine pragmatism as a theoretical framework 
and relate it to proposed African epistemic and validation frameworks with a particular 
reference to homegrown orthodox and alternative/complementary medicines. I argue 
that the validation and approval of any knowledge claim based on pragmatism is a more 
expeditious mode of attending to COVID-19 and other prevalent diseases in Africa. The 
application of knowledge that brings practical success in dealing with health challenges 
in Africa without necessarily following rigid and lengthy scientific validation procedures 
will go a long way toward improving human conditions and well-being. I conclude that 
pragmatic considerations should ultimately inform local approval to homegrown African 
medicines for use in Africa.
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I. Introduction
The outbreak of the coronavirus disease (COVID-19) from the city of Wuhan, China in December 2019 has spread to other countries by leaps and bounds, resulting in a massive loss of lives and affecting 
individuals, families, communities, and countries economically, socially, 
politically, and psychologically. The pandemic outbreak and an alarming 
death toll of thousands recorded globally have disproved the invulnerability 
of the most developed nations, superpower nations in particular, as well as 
exposed the susceptibility of the developing nations, especially African ones. 
Currently, the priority of nations is to defend their own interests, with Africa 
being left to its fate.1
Given Africa’s fragile economies and poor social protection systems, 
it is not absurd to think that the African continent will be the arena the 
virulent pandemic will play its final and enduring havoc with humanity. It 
is standard practice to require scientific evidence to corroborate any claim 
for the discovery of an effective vaccine or drug for the treatment of extant 
and novel diseases. However, the scientific process of the verification and 
validation of new vaccines/drugs for medical treatments is usually strict and 
lengthy.2 Vaccines have to undergo extensive clinical trials. They normally 
require at least two years of animal testing to ascertain their efficacy and 
safety before they are deemed safe enough for clinical trials in healthy human 
volunteers to determine their effectiveness in treating people.3
Such a rigorous process of establishing truth claim does not fit the bill 
in the case of the outbreak of virulent diseases like the COVID-19 pandemic. 
One may pose several questions. Can African countries afford to wait for the 
development of scientifically proven COVID-19 vaccines amidst the surging 
scourge and death toll of the pandemic in Africa? Is it not suicidal to wait for 
the rigorous and lengthy scientific processes of the verification and validation 
of COVID-19 vaccines, while the pandemic is fast scourging and decimating 
Africans? Given that the chief purpose of establishing a civil society is to 
protect lives and property and improve human welfare, is it not expedient to 
adopt any viable and efficient approach to the COVID-19 pandemic to save 
lives?
1 Charles C. Soludo, “Can Africa Afford COVID-19 Lockdowns?” Proshare, April 24, 2020, 
https://www.proshareng.com/news/NIGERIA%20ECONOMY/Can-Africa-Afford-COVID-19-
Lockdowns----Chkwuma-Soludo/50636#.
2 Cyril E. Ejike, “COVID-19 and African Traditional Medicines,” in COVID-19 and Afrocentric 
Perspectives: Health and Economic Implications, eds. Ikechukwu A. Kanu, Chiugo C. Kanu, and 
Ejikemeuwa J. O. Ndubisi (Maryland: The Association for the Promotion of African Studies, 
2021), 2.
3 Ejike, 2.
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Thus, looking inward in search of solutions to the pandemic is now at the 
forefront in the minds of well-meaning Africans. In response to the call for the 
adoption of a viable approach to myriads of health problems plaguing Africa, 
especially the novel COVID-19 pandemic, this paper aims at contending 
for the development, legitimization, and production of homegrown 
African medicines on a pragmatic basis as an ideal and positive response to 
COVID-19, subsequent pandemics, and other diseases that are rife in Africa. 
To this end, I will first explore pragmatism as a theoretical framework from 
which my arguments are developed. I will thereafter apply pragmatist theory 
in contending for the development and legitimization of Africa’s epistemic 
frameworks with particular reference to homegrown African medicines. This 
is followed by demonstrating that a pragmatic approach to knowledge and 
ideas requires standard and functional healthcare systems and education to be 
successful. I will thereafter discuss ethical issues involved in the development, 
production, and distribution of synthetic COVID-19 vaccines. Finally, I 
will conclude that pragmatic considerations should ultimately inform the 
approval of homegrown African medicines and other medical products by 
national health authorities in African countries for use in Africa.
II. Pragmatism
Pragmatism is a philosophical system or theory propounded by Charles 
Sanders Peirce and developed and popularized by William James. John 
Dewey and Richard Rorty were also influential pragmatist thinkers. 
The theory has been known by various names, e.g., functionalism, 
instrumentalism, workability, experimentalism, and progressivism. 
Pragmatism holds that our knowledge, ideas, thinking, and propositions 
are true and meaningful if they have practical consequences. The utility of 
an idea, belief, or knowledge is a good measure of truth value. In other 
words, it is the practical usefulness of an idea or knowledge that makes it 
true and meaningful. Therefore, pragmatism uses practical consequences 
of knowledge and ideas as a standard for determining their values and 
truth.
Pragmatism was first used in 1878 in Peirce’s article, How to Make 
Our Ideas Clear, where he states that “belief is a rule for action.”4 In 
this regard, Rorty asserts that the function of human mind is to produce 
practical ways of living, thus truth is simply “what passes for good belief.”5 
Proponents of this theory agree that truth is the property of certain ideas, 
4 Charles S. Pierce, “How to Make Our Ideas Clear,” Popular Science Monthly 12 (1878): 291. 
5 As quoted in Cheryl Misak, Truth, Politics, Morality: Pragmatism and Deliberation (London and 
New York: Routledge, 2002), 13. 
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but demand that such ideas must bear an action, that is, must be fruitful 
and useful in a sensible and practical way. James asserts thus:
The pragmatic method in such cases is to try to interpret each 
notion by tracing its respective practical consequences. What 
difference would it practically make to anyone if this notion 
rather than that notion were true? If no practical difference 
whatever can be traced, then the alternatives mean practically 
the same thing, and all dispute is idle. Whenever a dispute is 
serious, we ought to be able to show some practical differences 
that follow from one side or to the other’s being right.6
Pragmatism, for James, is therefore 
the doctrine that the whole ‘meaning’ of a conception expresses 
itself in its practical consequences either in the shape of conduct 
to be recommended or in that of experiences to be expected, if 
the conception be true.…7 
James explains that his pragmatic conception of meaning is grounded in 
Charles Peirce’s work:
Mr. Peirce, after pointing out that our beliefs are really rules for 
action, said that, to develop a thought’s meaning, we need only 
determine what conduct it is fitted to produce: that conduct 
is for us its sole significance…To attain perfect clearness in 
our thoughts of an object, then, we need only consider what 
conceivable effects of a practical kind the object may involve 
– what sensations are we to expect from it, and what reactions 
we must prepare. Our conception of these effects, whether 
immediate or remote, is then for us the whole of our conception 
of the object, so far as that conception has positive significance 
at all.8
An idea or knowledge does not count, for the pragmatist, if it has no 
practical bearing on our experiential world9 as, for James, “the possession 
6 William James, Pragmatism (Cambridge: Harvard University Press, 1975), 90.
7 James M. Baldwin, ed., Dictionary of Philosophy and Psychology, vol. 2 (New York: The 
Macmillan Company, 1902), 321.
8 James, 28-29.
9 John A. I. Bewaji, An Introduction to the Theory of Knowledge: A Pluricultural Approach 
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of true thoughts means everywhere the possession of invaluable instruments 
of action.”10 Therefore, the focus of pragmatism is essentially the utility of 
ideas, knowledge, or beliefs. In discussing William James’ pragmatic theory of 
truth, Schmitt asserts that an idea or belief is “true just in case it has practical 
utility in life or belongs to a system of beliefs that has practical utility.”11 
Therefore, for the pragmatist, the test of truth is utility, workability, and 
successful results.12
For pragmatists, truth is something that happens to an idea and the idea 
becomes true when it produces a satisfactory result. While empiricists take 
every sense perception cognitively and continuously, whether it is practically 
useful or not, pragmatists accept only ideas that are practically useful. James 
explicates thus:
True ideas are those that we can assimilate, validate, corroborate, 
verify. False ideas are those we cannot. That is the practical 
difference it makes to us to have true ideas; that, therefore, is the 
meaning of truth, for it is all that truth is known as. This thesis 
is what I have to defend. The truth of an idea is not a stagnant 
property inherent in it. Truth happens to an idea. It becomes true, 
is made true by events, its verity is in fact an event, a process: the 
process namely of its verifying itself, its verification. Its validity 
is the process of its validation.13
What the aforementioned assertions mean is that our ideas are true if they 
can be met with desired success or be successful in meeting our expectations. 
Pragmatism, obviously, does not discard science. In fact, it adopts scientific 
attitude in terms of verification in seeking true knowledge and in attending 
to human existential problems. Pragmatism underpins science in that it holds 
that true knowledge and ideas are hinged on practical success. However, its 
point of departure is that it takes a multi-faceted approach to verification 
and validation rather than being limited to rigid scientific verification and 
validation procedures. For instance, James asserts that the proposition that 
God exists is verifiable in the sense that we can ascertain whether it provides 
(Ibadan: Hope Publications, 2007), 238.
10 As quoted in Richard L. Kirkham, Theories of Truth. A Critical Introduction (Cambridge: The 
MIT Press, 1992), 92.
11 Frederick F. Schmitt, “Truth: An Introduction,” in Theories of Truth, ed. Frederick F. Schmitt 
(Oxford: Blackwell Publishing, 2003), 9.
12 Ben O. Eboh, Basic Issues in Theory of Knowledge (Nsukka: UNN, 1990), 44.
13 James, 97.
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us with “vital benefits,” that is, satisfies our spiritual or religious needs.14 Such 
a proposition is true; it works satisfactorily, if it meets such needs. Therefore, 
the verification and validation of knowledge claims, ideas, or propositions 
must not rest on scientific testing or experimental procedures.
Pragmatism turns away from abstractions, a priori reasons, static 
knowledge, fixed principles, and closed systems, but turns toward 
concreteness, facts, and actions.15 Peirce maintains that our pragmatic 
approach to scientific, philosophical, or theological questions should be: 
Consider what effects, that might conceivably have practical 
bearings, we conceive the object of our conception to have. 
Then, our conception of these effects is the whole of our 
conception of the object.16 
Thus, James views pragmatism as a method that has no dogmas and 
doctrines apart from its method. What pragmatists are driving at in this 
regard is that formulations in philosophy, theology, and science should 
be seen as only approximations (verisimilitude), rather than as absolute 
truths or knowledge, for such formulations offer us no conclusive answers 
or solutions to our existential problems. A single fixed formula makes an 
account of truth rigid, authoritarian, and doctrinaire in pragmatists’ view. 
They therefore insist that there is no single fixed formula and absolute truth 
but many truths, as there are many concrete successful actions in the truth 
process.
Thus, James distinguishes between what he calls tough-minded and 
tender-minded approaches to truth. A tough-minded approach would 
consider more scientific behavior in the truth process, whereas a tender-
minded approach would consider less scientific behavior in the truth 
process.17 Our approach to knowledge should be multi-faceted, for we 
know things from many different perspectives. The value of any theory, 
for pragmatists, does not rest in its internal verbal consistency, but in its 
ability to solve human problems. Thus, James asserts that for a theory or an 
idea to be meaningful, we “must bring out of each word its practical cash 
value,”18 that is, its experiential utility or usefulness, whether good or bad, 
the difference it makes for practical life.
14 Anthony Harrison-Barbet, Mastering Philosophy (London: Macmillan Education, 1990), 80.
15 Ome, and Amam, 330.
16 Peirce, 291. 
17 Samuel E. Stumpf, and James Fieser, Philosophy: History and Problems, 6th ed. (New York: 
McGraw-Hill, 2003), 399.
18 As quoted in Stumpf and Fieser, 398.
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 10/12/2021 10:05:34 |
[ 39 ]
CONATUS • JOURNAL OF PHILOSOPHY VOLUME 6, ISSUE 1 • 2021
Dewey, in his brand of pragmatism known as instrumentalism, holds that 
thinking and ideas are instrumental in solving practical human problems.19 He 
insists that inquiry into any knowledge claim should be empirical in method 
and practically motivated.20 He explains further that the term pragmatic 
means “only the rule of referring all thinking, all reflective considerations, to 
consequences for final meaning and test.”21 The truth of any knowledge claim 
is thus based upon its usefulness. For Dewey, the best test of the value of any 
idea or theory is to ask: 
Does it end in conclusions, which, when referred back to 
ordinary life-experiences and their predicaments, render them 
more significant, more luminous to us and make our dealings 
with them more fruitful? 22 
For Dewey, the act that will bring about the most successful outcome is 
the most valuable. Hence, Dewey frowns upon any system of education 
that involves learning without doing or practice, as such education will 
have no practical usefulness. Dewey’s instrumentalism is governed by the 
presuppositions of science, which recognizes the intimate connection between 
reflection and experiment, thought and action.23 Human minds are basically 
problem-solving instruments and the best ways to discover the instrumental 
means for problems are experience and experiment. 
Overall, pragmatists consider ideas and knowledge to be true and 
meaningful if they can help us make successful connections among various 
life experiences and can be brought to bear on our existential problems. Truth 
is what works; an idea, a belief, or knowledge is true and only true if it is 
functional, that is, if it yields a satisfactory result. Put differently, it is the 
functional values of ideas, beliefs, and knowledge that make them true.
III. Pragmatism and COVID-19 in Africa
As was explained in the preceding section, pragmatism does not preclude 
scientific requirements, albeit science may exclude certain things that 
evidently work. James maintains that a pragmatic approach to knowledge 
could be tough-minded and tender-minded. For example, while a tough-
minded pragmatist would seek a scientific sort of analysis of the effectiveness 
19 Stumpf, and Fieser, 405.
20 Ome, and Amam, 335.
21 Ome, and Amam, 336.
22 Stumpf, and Fieser, 405.
23 Stumpf, and Fieser, 406.
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of an herbal tonic from Madagascar in treating COVID-19 patients, a tender-
minded one would only concern themselves with the efficacy of the medicine 
in determining its truth claim. For James, both approaches to truth are valid 
in their own ways, provided that the object of inquiry (Madagascar’s herbal 
drink) fulfils its useful function. Therefore, a pragmatic approach to pandemics 
and other viral and common diseases in Africa must not involve rigorous and 
lengthy scientific validation processes.
Kuhn’s seminal work, The Structure of Scientific Revolutions, has shown that 
science does not stand the test of time, as it undergoes periodic revolutions, 
which he calls a paradigm shift from which a new normal science emerges.24 
Truth is paradigmatic as it is determined by the prevailing paradigm. However, 
paradigms are always subject to change such that new truth emerges from 
the new paradigm. To this extent, truth is not always the same: what is true 
in a previous paradigm may not be true (at least in part) in a new paradigm. 
There is never a complete overlap between paradigmatic problems that can 
be solved by the previous and the new paradigms.25 Kuhn’s main contention 
here is that scientific knowledge does not rest on any foundation of a single 
absolute truth. There are more truths as there are more successful practical 
proofs, thus there will never be a complete collection of truths.
Given that scientific methodology is lengthy, rigorous, and does not offer 
us a cast-iron guarantee, it behooves Africa to be open to the application of 
what brings practical success efficiently without necessarily following rigid 
scientific procedures. It calls for the adoption of a pragmatic approach to 
pandemics and other diseases that are rife in Africa. African countries can 
achieve this by developing and legitimizing their own epistemic paradigm that 
will pragmatically attend to myriads of health problems plaguing their people. 
Misak explains that, for pragmatism, truth and objectivity are matters of 
what is best for the community of inquirers to believe, that is, what “best fits 
with the evidence and argument.”26 In the wake of the COVID-19 pandemic, 
Africans have demonstrated that their richly endowed medicinal plants could 
be exploited in attending to their multifarious health problems, if legislation 
enables this and they are given an environment to thrive in.
For example, Madagascar, one of the smaller African countries, has stolen 
a march on the West by developing an herbal tonic from a medicinal plant 
known as Artemisia annua for the treatment of COVID-19 patients to the 
consternation of the World Health Organization (WHO). The herbal remedy 
for COVID-19 produced by Madagascan herbal research institutes has been 




http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 10/12/2021 10:05:34 |
[ 41 ]
CONATUS • JOURNAL OF PHILOSOPHY VOLUME 6, ISSUE 1 • 2021
practically tested and proved to be curative. The viability and efficacy of the 
herbal drink have led Presidents of some other African countries like Equatorial 
Guinea, Tanzania, Uganda, Egypt, Guinea-Bissau, and Senegal to recognize 
and promote it, while they ordered for it to be used for the treatment of 
COVID-19 cases in their respective countries.
Local medical researchers and scientists have also claimed to have 
discovered herbal medicines for the treatment of COVID-19. For instance, this 
is the case of the Iris Medical Foundation Drugs and Pharmaceutical founded 
by late Professor Paul Olisa Ojeih. This pharmaceutical company is committed 
to drug research, focusing on compounding drugs from plants and enzymes 
and synthesizing them into potent cures.27 The company informed the Federal 
Government of Nigeria that it developed an organic phytomedicine, known 
as Venedi Elixir, which is effective in treating COVID-19. The alleged curative 
drug is derived from the enzymes of pharmaceutically engineered plants used 
to treat complex viral infections.28 Moreover, in Nigeria, a Roman Catholic 
priest and one of the country’s foremost traditional medical practitioners, 
Reverend Father Raymond Arazu has proclaimed that the Anambra Traditional 
Medicine Board headed by him has developed a cure for COVID-19. 
Furthermore, a Benedictine monk and priest of the Roman Catholic Church, 
Reverend Father Anselm Gbenga Adodo, who is the founder of Nigeria’s first 
alternative medicine and research laboratory enterprise in 1997 known as 
Pax Herbal Clinic and Research Laboratories in Ewu, Edo State of Nigeria, 
has announced that the research center discovered a clinical COVID-19 
herbal drug and expressed their readiness to begin the mass production of the 
treatment drug immediately after its use has been approved.29 Adodo also 
discloses that they have herbal medicines, which they have been producing for 
over 25 years, for many diseases plaguing Africans, such as malaria, typhoid 
fever, hypertension, tuberculosis, hepatitis B, diabetes, asthma, prostate 
problems, male and female infertility, etc.30
Rather than pay attention to these claims, the Nigerian government is 
waiting desperately for experimental drugs to be used in testing prospective 




29 Rasheed Sobowale, “Why WHO Suspended Chloroquine Clinical Trial for COVID-19 
Treatment,” Vanguard Nigeria, May 29, 2020, https://www.vanguardngr.com/2020/05/why-
who-suspended-chloroquine-clinical-trial-for-covid-19-treatment/. 
30 Rasheed Sobowale, “EWU on COVID-19, SARS, Ebola: Inside Catholic Research Centre 
where Monks Cure with Herbs,” Vanguard Nigeria, May 17, 2020, https://www.vanguardngr.
com/2020/05/ewu-on-covid-19-sars-ebola-inside-catholic-research-centre-where-monks-
cure-with-herbs/.
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volunteer COVID-19 patients. This constitutes a master-slave mentality that 
shows strong preference toward being a comfortable slave, rather than being 
a free man;31 this attitude stunts indigenous development in Africa. It could 
be recalled that when US President Trump asserted that hydroxychloroquine 
and chloroquine might help treat COVID-19, without any scientific evidence 
backing up the claim, many COVID-19 victims in Africa, including those that 
had not contracted the disease, rushed to purchase, and even store up the 
drug. In China, the US, and other countries where the drug has been used 
experimentally in COVID-19 patients, there is no satisfactory clinical evidence 
that chloroquine is effective in preventing and managing the pandemic.32 
Observational research led by Mandeep Mehra of the Brigham and 
Women’s Hospital in the US, which was published on May 22, 2020, and other 
numerous scientific studies, suggest that chloroquine and hydroxychloroquine 
are ineffective in treating COVID-19 and might aggravate the disease and 
increase the death likelihood of COVID-19 patients, given the potentially 
serious side effects, particularly arrhythmias (irregular heartbeat) both 
drugs can produce.33 No wonder it was reported in March 2020 that three 
COVID-19 victims were hospitalized in the Lagos State of Nigeria after 
taking chloroquine.34 This huge rush to obtain the drug was mainly owing to 
the assertion made by someone from the West, a President of a superpower 
nation for that matter, despite the position of the WHO that any medication, 
the efficacy of which has not been proved based on clinical trials, should not 
be used to treat COVID-19. 
It is high time Africa refused to be needlessly tied to the West’s apron 
strings and took its destiny in its hands. Madagascar’s COVID-19 herbal 
remedy should serve as a real eye-opener for Africans to believe in themselves 
and their vast natural resources, and look inward in search of viable solutions 
for COVID-19 and other viral and common diseases in Africa. Other African 
governments should take their cue from the Madagascan government that 
employs its own knowledge and expeditious validation system to verify 
and validate the efficacy and safety of its COVID-19 herbal solution and 
thus endorse it for use without waiting for scientific validation processes. 
African countries should be committed to intense COVID-19 research and 
give attention to claims of breakthrough in the cure of COVID-19 by African 
31 Sunny Ikhioya, “The Master-Slave Syndrome,” Vanguard Nigeria, May 27, 2020, https://
www.vanguardngr.com/2020/05/the-master-slave-syndrome/.
32 Stephanie Busari, and Bukola Adebayo, “Nigeria Records Chloroquine Poisoning after 
Trump Endorses it for Coronavirus Treatment,” CNN, March 23, 2020, https://edition.cnn.
com/2020/03/23/africa/chloroquine-trump-nigeria-intl/index.html.
33 Sobowale, “Why WHO Suspended Chloroquine Clinical Trial for COVID-19 Treatment.” 
34 Busari, and Adebayo.
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scientists and alternative medical practitioners, rather than rely only on 
the WHO for COVID-19 remedies and co-opt their people to be used as 
experimental guinea pigs and lab rats for the WHO’s untested and unproven 
COVID-19 vaccines in support of its solidarity trials. 
Claims by local researchers and scientists to have developed curative 
medicines, whether modern, herbal, or alternative/complementary 
medicines, should be subjected to evaluation protocols, grounded on 
pragmatism, by national health authorities in different African countries; if 
the medicines successfully pass practical testing and verification, then they 
should be approved forthwith. Empirical evidence is not only obtained from 
lengthy scientific validation, but also from other practical experiences. 
Locally manufactured COVID-19 equipment and other medical equipment 
should be equally subjected to evaluation and verification on a pragmatic 
basis for possible approval for use in Africa. What we are driving at is 
that subjecting homegrown African medicines to safety, toxicological, 
and efficacy tests as well as clinical trials on volunteer patients, must 
not follow rigorous scientific validation processes. To rise to the myriads 
of health challenges confronting Africa, a viable and efficient mode of 
measuring and determining the effectiveness of homegrown medicines 
should be developed by the national health authorities in African countries. 
Homegrown medicines should be approved for use in Africa if they prove 
to be viable and efficacious after practical testing and verification. It is not 
necessary for Africa to wait for the scientific validation of its homegrown 
medicines by the WHO that seems to neither believe nor show enough 
interest in traditional or herbal African medicines.
The Madagascan government has demonstrated that rigorous 
and lengthy scientific validation processes are needless in the case of a 
health emergency, by approving the use of its discovered herbal tonic 
for the treatment of COVID-19 cases based on its own knowledge and 
validation system. Similarly, the Israeli health authority has approved for 
use a series of efficacious vaccines developed by the Israel Institute for 
Biological Research using its own validation system.35 In response, the 
Israeli President is planning to build a plant for the production of vaccines 
for the treatment of COVID-19 patients. In recognition of the need for 
heterodox approaches to the pandemic ravaging the world, the House of 
Representatives in Nigeria has called on the Nigerian government to ignore 
caution by the WHO against the use of any drug on COVID-19 patients 
the efficacy of which is not scientifically proven, and approve and support 
35 Tordue Salem, “COVID 19: Ignore WHO, Go for Local Cures, Reps Tell FG,” Vanguard 
Nigeria, May 13, 2020, https://www.vanguardngr.com/2020/05/covid-19-ignore-who-go-for-
local-cures-reps-tell-fg/. 
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the use of alternative locally developed remedies for the management and 
treatment of COVID-19 in Nigeria.36
Although a theory yields certain practices by explaining the rationale 
behind the practices, sometimes theories do not precede practices. For 
instance, Africans’ forebears used neem leaves (scientifically known as 
Azadirachta indica, but popularly known as Dogoyaro in the Hausa language) 
and other herbs to treat malaria for ages, but could not offer explanations for 
why the herbs worked. They did not know it was parasites that engendered the 
disease, how it got into the human blood system, and why quinine could cure 
the disease. However, today, we know that the disease is caused by malaria 
parasites, and that it enters the circulatory system when a female Anopheles 
mosquito infected with the parasite bites a person; the neem plant contains 
quinine that cures malaria and can also be used to treat similar diseases.
The practice of any discovery, such as the Madagascan COVID-19 herbal 
remedy, whose theoretical formulations (scientific explanations) are not yet 
developed, should be accepted on the grounds that it serves the purpose for 
which it is made, which in this case is to contain the COVID-19 pandemic. 
African herbal medicines and other homegrown medical products should not 
be dismissed because there is no available verifiable scientific knowledge 
of the whys and wherefores of their viability. The fact that a scientifically 
verifiable explanatory theory is not yet offered does not mean that it cannot 
be provided in the future. The efficacy of any medicine presupposes a workable 
theory behind it, albeit the explanation of such a theory may not be offered for 
the moment. Scientific explanations for why homegrown African medicines 
work can come later. Whatever passes the litmus test of pragmatism is a 
strong candidate for the test of scientificity. The success or effectiveness of 
the practical application of homegrown African medicines and other medical 
products should be the ultimate criterion for their endorsement for medical 
treatments in Africa. The fact that they pay off should be a justification for 
approving them, their scientific explanations pending. 
IV. On Health
The global life or death situation brought about by the outbreak of the 
COVID-19 pandemic had started before the first COVID-19 case in Africa 
was recorded in Egypt on February 14, 2020. Prior to Africa’s index case, 
the pandemic outbreak had become a cause for concern in the continent. 
The fact that the COVID-19 pandemic became a matter of considerable 
public concern was exacerbated by the weak healthcare systems of most 
African nations. Therefore, ultimately, Africa was apprehensive about its 
36 Salem. 
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level of preparedness and readiness to combat the virulent and deadly 
pandemic, especially when considering the fact that the pandemic had 
already overpowered robust health systems of some developed countries 
like Italy, Spain, and the United States.
Recently, African nations have somehow managed to tackle other 
disease outbreaks, such as Ebola virus disease, cholera, Lassa fever, and 
monkey pox outbreaks, without stepping up the medical treatments and 
preventive measures, or strengthening the respective health systems of 
the different nations. However, the COVID-19 pandemic is a completely 
different situation, as it overwhelms Africa and exposes its weak health 
systems. Thus, some African countries like Nigeria are already sitting ducks 
for the pandemic, given the plethora of understaffed, underequipped, and 
underfunded health care centers and hospitals that cannot provide the high 
quality and culturally appropriate healthcare services required to contain 
and manage the raging and ravaging pandemic.37 
The United Nations Development Programme’s (UNDP) report on 
current expenditure on healthcare suggests that the healthcare sector is 
badly underfunded in many African countries. For instance, healthcare 
expenditure in terms of the Gross Domestic Product (GDP) percentage spent 
on healthcare in 2015 was 2.5 in South Sudan, 3.3 in Eritrea, 3.6 in Nigeria, 
3.8 in Papua New Guinea, 4.0 in Benin, Senegal, and Ethiopia, 4.3 in the 
Democratic Republic of Congo, 4.5 in Guinea, 4.6 in Mauritania and Chad, 
5.2 in Madagascar, 5.4 in Côte d’Ivoire, Mozambique, and Burkina Faso, and 
5.8 in Mali.38 Therefore, it is not surprising that the COVID-19 pandemic 
has put a huge strain on the limited health services of African countries.
Many Africans do not have access to basic healthcare due to dilapidated 
hospital facilities and poor health service delivery. The low government 
expenditure on healthcare over the past years does not meet the global 
healthcare standards, thus African nations have low-rated healthcare 
systems. For instance, the healthcare system of Nigeria currently ranks 187th 
out of 191 healthcare systems globally.39 Drug research, development, and 
production are very expensive. Pharmaceutical research institutes across 
Africa cannot raise the funds required for drug research and development 
without the support of African governments and private investments that 
presupposes enabling laws and creating a favorable environment.
37 Sola Ogundipe, “How COVID-19 Rediscovered Nigeria’s Health Care System,” Vanguard 
Nigeria, May 29, 2020, https://www.vanguardngr.com/2020/05/special-report-how-covid-19-
rediscovered-nigerias-health-care-system/.
38 United Nations Development Programme, Human Development Indicators and Indices: 2018 
Statistical Update Team (New York: United Nations Development Programme, 2018), 52-53.
39 Ogundipe. 
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Recently, the US government approved a budget of $1 billion for 
AstraZeneca, a British-Swedish pharmaceutical company, to carry out 
research for a COVID-19 vaccine.40 This is how a government’s commitment 
to research and development is demonstrated. When drugs are developed and 
produced by local pharmaceutical industries, a high percentage of essential 
drugs will be available for domestic consumption, thereby reducing heavy 
dependence on the importation of drugs from foreign countries to meet local 
needs. This is necessary, especially in the case of a pandemic outbreak that 
can only be contained by lockdowns and border closure.
Some African countries like Nigeria that were affected the most by the 
COVID-19 pandemic, had a scarcity of essential drugs at the onset of the 
pandemic outbreak due to lockdowns and border closures in China and India, 
where most essential drugs are imported from. For a pragmatic approach to 
work, the healthcare systems of African nations must improve. It cannot be 
rightly gainsaid that Africa cannot respond to a pandemic and other prevalent 
African diseases, such as malaria, typhoid fever, cholera, Lassa fever, 
tuberculosis, diarrhea, small pox, hepatitis, yellow fever, measles, cancer, 
stroke, diabetes, and coronary heart diseases in a pragmatic way if healthcare, 
health workers, and health facilities are inadequate. This is mainly because the 
aforementioned are indispensable instruments for the practical application 
of homegrown African medicines. They are the means through which viable 
orthodox, alternative, and herbal medicines can be administered to people.
Therefore, the proposed pragmatic approach to Africa’s multifarious 
health problems calls for the provision of adequate healthcare centers 
and hospitals, the employment of sufficient, experienced, and well-trained 
healthcare workers, and the provision of adequate and state-of-the-art 
medical facilities across states or regions in all African countries. Besides, 
government expenditure in healthcare as well as government and private 
investments in the pharmaceutical sector for the research, development, and 
production of drugs are critical to implement improvements in the various 
healthcare systems.
Monitoring and stemming the spread of a pandemic requires effective 
and early testing. Tedros Ghebreyesus, the Director-General of the WHO, 
discloses that “lack of testing is leading to a silent epidemic in Africa.”41 
Testing early and often ensures that carriers of the pandemic are detected 
and isolated to minimize the rate of contagion. By March 2020, when the 
COVID-19 pandemic had reached epidemic proportions in Europe, the fatality 
40 Ibid.
41 Premium Times, “WHO Fears ‘Silent’ Virus Epidemic unless Africa Prioritises Testing,” May 
26, 2020, https://www.premiumtimesng.com/news/top-news/394580-who-fears-silent-virus-
epidemic-unless-africa-prioritises-testing.html. 
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rate of Germany was remarkably low (0.5%),42 compared to those of Italy 
(10%), Spain (8.9%), and France (5%). Drosten, whose team of researchers 
developed the first COVID-19 test that was publicly available, attributes the 
low fatality rate of Germany to the ability of his country to test early and 
often.43 He discloses that Germany has been testing approximately 120,000 
people a week for COVID-19 since late February 2020 which helped the 
country stand out among the worst hit countries in Europe.44
To respond robustly and positively to COVID-19 and subsequent 
pandemics, testing sites must be created across states/regions of African 
countries. Africa must not wait until a new pandemic breaks out before it 
starts getting on the stick, for it is not good at flattening the curve. The 
most efficient means of achieving this is to set up ultra-modern molecular 
and diagnostic laboratories that have the capacity to undertake thousands 
of tests per day in all university teaching hospitals (UTHs) across states of 
African countries. The UTHs could easily be converted into testing centers 
during a pandemic outbreak, after receiving accreditation by the Center for 
Disease Control in each African country.
V. On Education
For a pragmatic approach to be effective, university lecturers must be 
encouraged and supported to be fully committed to research and development, 
through improved salaries and allowances as well as the provision of adequate 
research grants and educational facilities. Students, particularly those that 
take medical and pharmaceutical related courses, need a holistic experience 
and pragmatic education that involves learning and practicing, which will 
equip them with the necessary skills, knowledge, ideas, materials, and tools 
to excel in all spheres of their future careers and work in a pragmatic way in 
attending to future life challenges that may confront them and their people. 
Africa needs medical and pharmaceutical lecturers and researchers 
in ivory towers to be at the forefront of research in viable homegrown 
medicines (modern or herbal) to tackle myriads of the health problems 
plaguing Africa. However, these ideals are not attainable unless there are 
improved conditions of service, an adequate provision of state-of-the-art 
laboratories and lab equipment, and an increase in governmental expenditure 
on research and development. Some groundbreaking medical research is lying 
42 Rob Schmitz, “Why Germany’s Coronavirus Death Rate Is Far Lower Than in Other 
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dormant in university libraries across Africa. Enormous funds are required for 
the development and production of medical discoveries. 
Regrettably, education is chronically underfunded by African governments. 
The United Nations Children’s Fund recommends that developing countries 
should allocate no less than 15% of their annual budgets to education. 
However, over the past years, developing African countries have consistently 
failed to provide the bare minimum of allocation to maintain acceptable 
educational standards in Africa. Thus, the African education system is waning. 
In Nigeria, for example, there has been a steady decline in the education 
budget. According to the “2020 Budget Analysis and Opportunities” report, 
the budget for education was 12.3%, 9.3%, 7.3%, 7.1%, and 6.5% in 2015, 
2016, 2017, 2018 and 2019, and in the pre-COVID-19 2020 budget, 
respectively.45
The 2018 UNDP report on government expenditure on education 
measures in terms of the GDP percentage allotted to education during 2012–
2017 shows that the education expenditures of South Sudan (1.8%), Guinea-
Bissau (2.1%), Madagascar (2.1%), the Democratic Republic of the Congo 
and Uganda (2.3%), Guinea (2.4%), Mauritania (2.6%), Cameroun, Gambia, 
and Liberia (2.8%), and Chad (2.9%) were negligible.46
VI. On Ethics
Morality is the basis of ethics and eudaimonia (happiness, welfare/human 
flourishing) is the standard of morality. Aristotle asserts that happiness is the 
supreme good for all human beings, albeit there is no general consensus as 
to what sort of life counts as happy or what happiness actually consists of.47 
However, in general, all human beings as moral agents have the right to life, 
liberty, and security, while the society of which they are parts has a moral 
obligation to protect these rights. Therefore, security and freedom to choose 
how to lead one’s life as well as treating all humans with care and respect are 
basic principles of a good society.48
COVID-19 vaccine experimentation, development, production, and 
allocation as well as COVID-19 inoculation/vaccination raise certain ethical 
concerns. How could a limited supply of early vaccines be allocated or 
distributed fairly and effectively? Who should be prioritized in the vaccine 
45 Vanguard Nigeria, “How COVID-19 Can Help Nigeria Rethink Education Policy – AACS,” 
May 27, 2020, https://www.vanguardngr.com/2020/05/how-covid-19-can-help-nigeria-
rethink-education-policy-%E2%80%95-aacs/.
46 United Nations Development Programme, 56-57.
47 Aristotle, The Nichomachean Ethics of Aristotle, 10th ed., trans. F. H. Peters (London: Keegan 
Paul, Trench, Trübner & Co., 1906), 1094a.
48 Barry Knight, Rethinking Poverty: What Makes a Good Society? (Bristol: Policy Press, 2017), 89.
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distribution? What ethical values should guide the vaccine allocation to 
maximize benefits – the overall number of lives saved? Do the benefits of 
the synthetic vaccine outweigh the risks associated with its clinical trials and 
the pandemic inoculation/vaccination? Can we ever justify on moral grounds 
human lives wasted during inoculation? Are COVID-19 vaccines worth, 
in terms of their effectiveness, enormous public funds allocated for their 
research, development, production, and procurement?
As noted earlier, synthetic vaccines are required to pass rigorous safety 
and efficacy standards. It usually takes at least two years for the vaccines to 
undergo animal tests before clinical trials, thus vaccine research, development, 
and production could potentially take up to a decade. Experience from the 
2009 pandemic influenza A (H1N1) virus as well as the onset of the COVID-19 
pandemic shows that there is a proclivity for the world’s leading economies 
to place their national interests in research, development, production, and 
distribution of vaccines above global interests.49 Vaccine nationalism, which 
entails a desire and push by a nation to first get access to a vaccine supply 
and dictate vaccine production and distribution in its favor, raises some moral 
questions.
For instance, at the onset of the COVID-19 pandemic, superpowers, such 
as the US, China, and Russia, competed for the development of a COVID-19 
vaccine and for who would become the first supplier. This intense rivalry 
among superpowers induced them to speed up their vaccine development and 
production with regard to clinical trials and pushed for quicker regulatory 
approval. For instance, the AstraZeneca and Moderna COVID-19 vaccines 
were approved for public use in November (which is less than a year after the 
pandemic outbreak) and December (which is just year after the outbreak of the 
pandemic), respectively. There are grave risks associated with hasty clinical 
trials and regulatory approval. The efficacy and safety scientific standards of 
COVID-19 vaccines might be compromised, thus constituting the vaccines 
unable to effectively treat the viral infection, protect people against it, and 
help achieve herd immunity; global herd immunity is achieved when a sufficient 
part of the population becomes immune to a virulent disease to such an 
extent that the spread of the disease is contained. If vaccines developed and 
produced in this manner turn out to be less effective, or have unconscionable 
harmful side effects, national vaccination plans would be complicated and 
global vaccine supply chains would be interrupted, thus frustrating further 
any globally coordinated efforts to contain the pandemic. 
The AstraZeneca/Oxford vaccine is a case in point. Though the vaccine 
is widely used by most countries for large-scale vaccination programs, it 
49 Macro Hafner, et al., COVID-19 and the Cost of Vaccine Nationalism (Santa Monica, 
California, and Cambridge, UK: Rand Corporation, 2020), iii.
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does not offer a guarantee of treating COVID-19. In a study, a volunteer 
suffered from a neurological condition known as transverse myelitis – a 
“possibly related severe side effect”50 of the vaccine – after participating in a 
clinical trial. Furthermore, a 49-year-old nurse succumbed to severe bleeding 
disorders days after receiving the vaccine, which forced Denmark, Australia, 
Lithuania, and a few other countries to halt vaccinations with doses of the 
vaccine from the same batch.51 What is more, the UK report on the AstraZeneca 
vaccine disclosed that 547 people had died from adverse side effects of the 
inoculation between January 4 and March 9, 2021.52 Some other countries 
like France, Germany, Italy, Norway, and Sweden have suspended the use of 
the AstraZeneca shot due to reports of European Union (EU) countries citing 
its possible serious side effects, especially cases of post-jab hemorrhages. 
In this regard, a rational mind may ask: Can we morally justify deaths and 
harm resulting from severe side-effects of the vaccine? Herein, we shall consider 
two ethical perspectives, namely, deontological and teleological theories. 
According to deontologists, certain actions, which border on human values 
like killing, are wrong ontologically, that is, in their very nature, and neither 
circumstances nor consequences can make them rights.53 Peschke contends 
that “the judgement of the morality of an action is not possible without a 
careful study of the nature of being, that is without due consideration of the 
deontological factors involved.”54 In their view, the nature of a being and 
the nature of an action are ultimate criteria for making moral judgements. 
However, the circumstances and consequences (intended or anticipated) are also 
considered in making moral decisions. For the teleologists/consequentialists, 
the rightness or wrongness of an action is determined by the consequences 
(good or evil) resulting from the action,55 regardless of the nature of an action 
or the means of achieving the end. This approach to making moral decisions 
considers an action as morally right if its good consequences outweigh bad 
ones. Teleologists want moral agents to focus only on the ultimate end or goal 
50 As quoted in Vanguard Nigeria, “Five Things to Know about the AstraZeneca/Oxford 
Vaccine,” March 11, 2020, https://www.vanguardngr.com/2021/03/five-things-to-know-
about-the-astrazeneca-oxford-vaccine/.
51 Medical Express, “Five Things to Know about the AstraZeneca/Oxford Vaccine,” March 21, 
2021, https://medicalxpress.com/news/2021-03-astrazenecaoxford-vaccine.html.
52 Nneoma Benson, “275 Dead: UK Report on AstraZeneca Vaccine Sends Message of Caution 
to Nigeria, Others,” The Whistle, March 16, 2021, https://thewhistler.ng/275-dead-uk-report-
on-astrazeneca-vaccine-sends-message-of-caution-to-nigeria-others/.
53 Joseph I. Omoregbe, Ethics: A Systematic and Historical Study (Lagos: Joja Educational 
Research and Publishers Limited, 1993), 73.
54 Karl-Heinz Peschke, Christian Ethics, 3rd ed., vol. 1 (Oregon: Wipf and Stock Publishers, 
2012), 134.
55 Ben O. Eboh, Living Issues in Ethics (Nsukka: Afro-Orbis Publishing Co. Ltd, 2005), 78.
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of an act in making moral decisions. However, the ultimate end is very difficult 
to evaluate, as there are different definitions of ultimate goals resulting from 
different forms of teleology with different criteria and evaluation outcomes.56 
Besides, it is very difficult to determine all the proximate and remote 
consequences of an action and weigh them appropriately.57
Deontologists will argue that the victims of the harmful effects of the 
COVID-19 vaccine possess dignity and rights to life and security as others, and 
they did not implore to be killed. Hence, it is unethical to denude them of their 
right to life unsolicitedly. For consequentialists, the death of the COVID-19 
vaccine victims is an unintended consequence of the vaccine that is meant to 
save lives, thus the benefits outweigh the risks. However, a risk-benefit analysis 
in vaccine experimentation and pandemic inoculation/vaccination is very 
difficult to undertake. Such a task would require detailed information about 
the consequences of the vaccine, empirical insights, and knowledge of all 
contingencies. Thus, the risk-benefit ratio seems to be indeterminate. Besides, 
due to severe side-effects associated with synthetic vaccines, COVID-19 
vaccine experimentation and inoculation against the pandemic present more 
than minimal risks. A risk is said to be minimal if 
the probability and magnitude of harm or discomfort anticipated 
[…] are not greater in and of themselves than those ordinarily 
encountered in daily life or during the performance of routine 
physical or psychological examinations or tests.58 
Given that the risks associated with new synthetic vaccine experimentation 
and inoculation against a viral infection are anticipated and this incurs more 
than minimal risks, one may be inclined to think that it amounts to treating 
human subjects, who are ends in themselves by virtue of their inherent 
dignity, as a means to an end. This constitutes an affront to human dignity. 
In any case, nations of the world have to balance the need to protect the 
greatest number of people with the need to adequately understand how a 
new synthetic vaccine will perform (including its likely harmful side-effects) 
and protect people when administered. Regrettably, national governments 
have failed to balance this need as regards the development, production, 
allocation, and administration of COVID-19 vaccines.
Again, COVID-19 vaccines need not only to be effective but also to 
be administered to large portions of the global population to achieve 
56 Peschke, 128.
57 Ibid., 131.
58 As quoted in Vasantha Muthuswamy, “Ethical Issues in Clinical Research,” Perspectives in 
Clinical Research 4, no. 1 (2013): 10.
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herd immunity. Wealthier countries have signed direct bilateral deals with 
COVID-19 vaccine manufacturers to secure a stock for their own population.59 
The saying that he who pays the piper calls the tune still holds true. For 
instance, the AstraZeneca vaccine, which was first approved for use in Britain 
that earlier ordered 100 million doses of the vaccine, has been constantly 
supplied by the British-Swedish firm to Britain to meet its demand, while the 
firm delays the delivery of doses of the vaccine to other EU member states, 
thus frustrating their vaccination programs.60 In January, the firm announced 
that “it could only deliver one-third of the 120 million doses initially promised 
the 27 EU member states in the first quarter,”61 which prompted the EU to 
invoke a Brexit deal protocol over export controls on COVID-19 vaccines. 
European Commission President, Ursula von der Leyen disclosed that the firm 
had delivered less than 10% of the doses ordered by other EU member states 
between December 2020 and March 2021, warning that other countries 
could block exports.62
Thus, the vaccine may not be adequately allocated to low-income 
and middle-income countries that house approximately 85% of the global 
population.63 Wealthier countries might even hoard vaccine doses above and 
beyond their populations’ needs; after all, they can afford it. As high-income 
countries scramble for limited vaccine supplies, low-income countries that 
could not fund vaccine production are abandoned to their fate. Consequently, 
early available vaccines are not equitably allocated, and poorer countries do 
not have access to them. However, what is the moral justification for spending 
humongous public funds on the research, production, and procurement 
of COVID-19 vaccines, if the global population is far from attaining herd 
immunity? Given the increasing health costs and financial constraints worldwide, 
traditional bilateral and multilateral African development partners do not have 
the financial wherewithal to wholly fund COVID-19 vaccination programs in 
Africa.64 
Therefore, African governments still have to allocate millions of dollars 
for the vaccine procurement to vaccinate/inoculate their teeming population. 
59 Hafner, et al., iv.
60 Vanguard Nigeria, “Five Things to Know about the AstraZeneca/Oxford Vaccine.” 
61 Ibid.
62 Ibid.
63 Olivers J. Wouters, et al., “Challenges in Ensuring Global Access to COVID-19 Vaccines: 
Production, Affordability, Allocation, and Deployment,” Health Policy 397, no. 10278 (2021): 
1025.
64 Danielle Serebro, “COVID-19 Vaccine Financing and Purchasing in Africa: Wherefrom 
the Money?” CABRI, February 19, 2021, https://www.cabri-sbo.org/en/blog/2021/covid-19-
vaccine-financing-and-purchasing-in-africa-wherefrom-the-money.
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If the two-fold objectives of the vaccine, namely, the direct protection of a 
sufficient percentage of the global population and the containment of the viral 
transmission cannot be achieved, on account of vaccine nationalism and global 
competition, this then amounts to a waste of public funds that could have been 
channeled into cushioning the adverse economic effects of the pandemic on 
Africans through the provision of carefully planned and coordinated fiscal and 
monetary stimuli and job creations to enhance people’s well-being. COVID-19 
vaccines are designed for the treatment of the vast majority of patients and the 
protection of the global population so as to achieve herd immunity and improve 
the well-being of the human race. However, if economic power determines who 
and when gets the vaccines as well as the quantity allocated, then we can safely 
assert that the two-fold objectives are far from being achieved.
Besides, this “my nation first” approach to COVID-19 vaccine production 
means that low-risk individuals in high income countries get vaccinated or 
inoculated first before high-risk individuals in low-income countries who might 
even die before the vaccine is made available in their countries. Therefore, 
vaccine nationalism or global competition tends to prevent the vaccine from 
reaching relatively high-risk individuals early. One cannot help but wonder 
if there is any moral justification for administering COVID-19 vaccines first 
to low-risk individuals rather than high-risk individuals, regardless of their 
countries. Also, if the vaccines are meant to save lives, is it morally right to 
give priority to low-risk individuals on the basis of vaccine nationalism or 
global competition? Avoidable deaths and serious harm ensue from failure 
to prioritize relatively high-risk groups – vulnerable people and front-line 
workers – in vaccine allocation, irrespective of their countries. This problem 
is compounded by inequitable access to early vaccination in economically 
disadvantaged countries after the late and insufficient supply of vaccines, as 
these are not accessible and available to all people and only the affluent could 
afford them. According to Wu et al., “allocation guidelines must balance the 
obligation to assist individuals most likely to benefit against the obligation 
to secure the greatest aggregate benefit across the population.”65 Vaccine 
allocation should also be guided by considerations of fairness, which entails 
taking into account categories of people such as frontline health workers 
and vulnerable people who are suffering from chronic diseases like asthma, 
diabetes, and heart diseases and thus are more susceptible to COVID-19 
infection. Therefore, early vaccine allocation and use seem to be devoid of 
any value of fairness. 
However, these ethical issues involved in synthetic vaccines do not arise 
in the development, production, and administration of herbal and alternative/
65 Joseph H. Wu, et al., “Allocating Vaccines in a Pandemic: The Ethical Dimension,” The 
American Journal of Medicine 133, no. 11 (2020): 1241.
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complementary medicines in Africa. For instance, the gaping inequality in 
synthetic vaccine distribution, access, and use is bridged in the distribution of 
herbal and alternative medicines in Africa, owing to their availability, variety, 
accessibility to all, and low cost. Moreover, herbal and alternative medicines 
are natural remedies with minimal or no harmful side-effects and they have 
been shown to be effective in treating and managing viral infections at 
their early stages in the human body. They have the capability to boost and 
regulate an innate immune system to respond effectively to harmful alien 
antigens of a virus and prevent the virus from attaching its spike protein to 
human cells, thus forestalling the propagation and replication of the virus in 
the human host. For instance, a study by Ngcobo et al. conducted to evaluate 
the effects of African herbal tonics on immune and inflammatory responses 
using peripheral blood mononuclear cells, THP-1 monocytes, and bacteria-
infected rats, showed that the tonics stimulate the secretion of cytokines, 
which interact with innate immune system cells to regulate the body’s 
response to viral infections as well as inflammatory responses without any 
significant toxicity.66
It is no wonder that herbal extracts from Andrographis paniculata 
(commonly known as green chiretta) have been approved by the Food and 
Drug Administration (FDA) of Thailand to serve as alternative treatments 
for COVID-19, owing to their efficacy in curbing the viral infection and 
curtailing drastically the severity of inflammation. Thai’s government 
official, Taweeslip Witsanuyotin, who is a spokesperson for the national 
COVID-19 response center, noted that human trials showed that if the 
herbal medicine is administered on a patient within hours of testing positive, 
his/her condition improves within three days of the treatment without side 
effects.67 According to the chairman of the Bioresources Development 
Group, Professor Maurice Iwu, empirical data on InterCEDD, known as 
the “IHP Detox Tea,” which contains Andrographis paniculata as its key 
ingredient, and is produced by the group, overwhelmingly revealed that the 
herbal drug is highly efficacious in treating COVID-19 at its early stage.68
Furthermore, herbal and alternative/complementary medicines are 
extremely versatile in terms of their potential to treat and manage all kinds 
of viral infections and other diseases at their early stages in the human 
66 Mlungisi Ngcobo, et al., “The Immune Effects of an African Traditional Energy Tonic In 
Vitro and In Vivo Models,” Evidence-Based Complementary and Alternative Medicine 6310967 
(2017): 10. 
67 As quoted in Chris Onuoha, “COVID-19: Iwu Restates Efficacy of Herbal Medicine,” 
Vanguard Nigeria, January 10, 2021, https://www.vanguardngr.com/2021/01/covid-19-iwu-
restates-efficacy-of-herbal-medicine/.
68 As quoted in Onuoha, “COVID-19: Iwu Restates Efficacy of Herbal Medicine.” 
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body; however, synthetic vaccines lack that versatility. A synthetic vaccine 
is basically developed and produced by attenuating or inactivating whole 
or fragmented structural proteins of a disease-causing virus that can 
induce immune responses and neutralize antibodies in infected humans. 
For instance, the AstraZeneca vaccine is made by modifying a portion of 
the spike protein (antigen) of the SARS-CoV-2 in order to stimulate the 
production of antibodies and an adaptive immune system that recognizes 
the novel coronavirus.69 A synthetic vaccine is therefore designed to combat 
a particular pathogen and protect humans from it by developing adaptive 
immunity to an infection.
Accordingly, a synthetic vaccine within the context of viral infections 
is tailored to treat a specific strain of a virus and not all viral strains. 
Thus, the COVID-19 vaccine is prone to be less effective in treating other 
coronavirus variants. The emergence of a new coronavirus strain would 
therefore require further extensive research and studies to develop and 
produce a vaccine with all the accompanying extravagant financial demands 
and further clinical trials with great risks involved. For example, the 
Republic of South Africa (RSA) has paused the rollout of the AstraZeneca 
vaccine after a study showed that the vaccine offered “minimal protection 
against a mild and moderate new COVID-19 variant recently identified 
first in RSA.”70 On the whole, the moral and pragmatic values of herbal 
and complementary/alternative medicines lie in their efficacy, versatility, 
availability, accessibility, affordability, and minimal or no harmful side 
effects. 
VII. Conclusion
In this paper, I argued that a pragmatic approach to COVID-19 and other 
common diseases in Africa is among the most efficient and effective ways 
of dealing with myriads of health problems plaguing Africans. Pragmatism 
does not negate science, rather it affirms it. It only differs from science in 
that it insists that a practically verified successful idea/knowledge need not 
pass through rigorous and scientific processes of validation before it can 
be recognized and endorsed. It adopts a scientific attitude toward ideas 
and knowledge, but at the same time remains open to other modes of 
verification that can establish efficiently the workability of any idea, belief, or 
knowledge. Such a flexible approach to knowledge ensures that the approval 
69 Vanguard Nigeria, “Five Things to Know about the AstraZeneca/Oxford Vaccine.” 
70 Vanguard Nigeria, “UK Says Confident in COVID-19 Vaccines as S. Africa Pauses AstraZeneca 
Rollout,” February 8, 2021, https://www.vanguardngr.com/2021/02/uk-says-confident-in-
covid-19-vaccines-as-s-africa-pauses-astrazeneca-rollout/.
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of the utilization of any knowledge or idea that is practically successful is not 
delayed or rubbished by rigorous and lengthy processes of verification and 
validation.
Therefore, adopting a pragmatic approach to knowledge does not imply 
that Africa discards science, rather it suggests that Africa is opening its mind to 
other practical and efficient modes of testing and verifying the workability of any 
knowledge claim for the possible utilization of such knowledge in attending to 
Africa’s existential problems. Empirical evidence does not only rest on scientific 
validation, but also on other practical experiences. Accordingly, if the practical 
application of any idea is successful, then it is empirical. Any pandemic outbreak 
is a matter of life and death. It is suicidal to wait for the lengthy scientific 
validation of new synthetic vaccines. Hence, Africa’s approach to COVID-19 
and other pandemics should be predicated on what works efficiently. 
Just as the outbreak of COVID-19 breaks all cultural, social, economic, 
political, and religious protocols precipitously, an approach to the pandemic 
should breach scientific protocol, provided that the approach is practically 
effective and efficient. An African proverb from the Igbo people of Nigeria that 
desperate situations call for desperate measures (Anụ gba ajọ ọsọ, a jụjụa ya 
ajọ egbe) gives credence to the aforementioned assertion. Therefore, it calls 
for the development and legitimization of Africa’s epistemic system grounded 
in pragmatic principles. Pragmatic considerations should ultimately inform 
the approval of homegrown African medicines and other medical products by 
national health authorities in African countries for use in Africa. Homegrown 
orthodox and alternative/complementary medicines should be approved if they 
prove to be effective based on Africa’s own knowledge and validation system. 
Ultimately, what matters is that the end-result is successful – the medicines 
work well in practice. 
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